Login / Signup

LincRNA-EPS impairs host antiviral immunity by antagonizing viral RNA-PKR interaction.

Jingfei ZhuShengchuan ChenLi-Qiong SunSiying LiuXue BaiDapei LiFan ZhangZigang QiaoLiang LiHaiping YaoYu XiaPing XuXiaohui JiangZhengrong ChenYongdong YanFeng Ma
Published in: EMBO reports (2022)
LincRNA-EPS is an important regulator in inflammation. However, the role of lincRNA-EPS in the host response against viral infection is unexplored. Here, we show that lincRNA-EPS is downregulated in macrophages infected with different viruses including VSV, SeV, and HSV-1. Overexpression of lincRNA-EPS facilitates viral infection, while deficiency of lincRNA-EPS protects the host against viral infection in vitro and in vivo. LincRNA-EPS -/- macrophages show elevated expression of antiviral interferon-stimulated genes (ISGs) such as Mx1, Oas2, and Ifit2 at both basal and inducible levels. However, IFN-β, the key upstream inducer of these ISGs, is downregulated in lincRNA-EPS -/- macrophages compared with control cells. RNA pulldown and mass spectrometry results indicate that lincRNA-EPS binds to PKR and antagonizes the viral RNA-PKR interaction. PKR activates STAT1 and induces antiviral ISGs independent of IFN-I induction. LincRNA-EPS inhibits PKR-STAT1-ISGs signaling and thus facilitates viral infection. Our study outlines an alternative antiviral pathway, with downregulation of lincRNA-EPS promoting the induction of PKR-STAT1-dependent ISGs, and reveals a potential therapeutic target for viral infectious diseases.
Keyphrases
  • cell proliferation
  • mass spectrometry
  • sars cov
  • dendritic cells
  • immune response
  • oxidative stress
  • infectious diseases
  • induced apoptosis
  • transcription factor
  • gene expression
  • poor prognosis
  • dna methylation